IC

Initiative Capital Romandie

Europe, Vaud, Switzerland, Lausanne

Description

Initiative Capital Romandie is a private equity fund that focuses on technology companies based in Western Switzerland.

Investor Profile

Initiative Capital Romandie has made 9 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (33%)
  • Series C (22%)
  • Series B (22%)
  • Series E (11%)
  • Series Unknown (11%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Health Care
  • Medical Device
  • Biotechnology
  • Health Diagnostics
  • Neuroscience
  • Brand Marketing
  • Fitness
  • Marketing
  • Medical
  • Personal Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Initiative Capital Romandie frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 1
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 4
Sectoral Asset Management
North America, Quebec, Canada, Montréal
Co-Investments: 1
Fongit Seed Invest
Europe, Geneve, Switzerland, Plan-les-ouates
Co-Investments: 2
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 2
NGN Capital
North America, New York, United States, New York
Co-Investments: 1
Banexi Ventures
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
BB Biotech Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 4
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 2

What are some of recent deals done by Initiative Capital Romandie?

Aleva Neurotherapeutics

Lausanne, Vaud, Switzerland

Aleva Neurotherapeutics has developed proprietary neurostimulation platform based on microDBS Technology.

Health CareHealth DiagnosticsMedical DeviceNeuroscience
Series EDec 16, 2019
Amount Raised: $8,135,803
PicoDRILL

Lausanne, Vaud, Switzerland

PicoDrill SA provides micromachining techniques for production of hole structures in glass and dielectric materials.

Nanotechnology
Series AAug 1, 2017
Amount Raised: $6,007,742
Aleva Neurotherapeutics

Lausanne, Vaud, Switzerland

Aleva Neurotherapeutics has developed proprietary neurostimulation platform based on microDBS Technology.

Health CareHealth DiagnosticsMedical DeviceNeuroscience
Series CMay 27, 2016
Amount Raised: $18,000,000
Endosense

Geneva, Geneve, Switzerland

Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CNov 27, 2013
Amount Raised: $41,185,254
Diagnoplex

Lausanne, Vaud, Switzerland

Diagnoplex develops non-invasive colorectal cancer screening tests and diagnostics.

BiotechnologyMedical Device
Series UnknownJun 7, 2013
Amount Raised: $1,389,893
Aleva Neurotherapeutics

Lausanne, Vaud, Switzerland

Aleva Neurotherapeutics has developed proprietary neurostimulation platform based on microDBS Technology.

Health CareHealth DiagnosticsMedical DeviceNeuroscience
Series BApr 10, 2012
Amount Raised: $4,355,941
Aleva Neurotherapeutics

Lausanne, Vaud, Switzerland

Aleva Neurotherapeutics has developed proprietary neurostimulation platform based on microDBS Technology.

Health CareHealth DiagnosticsMedical DeviceNeuroscience
Series AAug 25, 2011
Amount Raised: $13,667,629
Viroblock

Geneva, Geneve, Switzerland

Viroblock is a Swiss company focused on developing a novel anti-viral technology suited for air filtration products.

BiotechnologyBrand MarketingFitnessHealth CareMarketingMedicalPersonal HealthTechnical SupportWellness
Series BFeb 5, 2010
Viroblock

Geneva, Geneve, Switzerland

Viroblock is a Swiss company focused on developing a novel anti-viral technology suited for air filtration products.

BiotechnologyBrand MarketingFitnessHealth CareMarketingMedicalPersonal HealthTechnical SupportWellness
Series AJul 20, 2007